Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Solis

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Plos Pathogens|August 30, 2024
Step-wise evolution of azole resistance through copy number variation followed by KSR1 loss of heterozygosity in Candida albicansPétra Vande Zande, Cécile Gautier, Nora Kawar, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A genome-scale screen identifies sulfated glycosaminoglycans as pivotal in epithelial cell damage by <i>Candida albicans</i>Jianfeng Lin, Jian Miao, Katherine G Schaefer, et al.
Nature Microbiology|September 16, 2024
Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysinJianfeng Lin, Jian Miao, Katherine G Schaefer, et al.
Molecular Imaging and Biology|August 23, 2021
<sup>124</sup>I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 InfectionCamilo A Ruiz-Bedoya, Filipa Mota, Alvaro A Ordonez, et al.
Plos Pathogens|October 23, 2015
The Fungal Exopolysaccharide Galactosaminogalactan Mediates Virulence by Enhancing Resistance to Neutrophil Extracellular TrapsMark J Lee, Hong Liu, Bridget M Barker, et al.
The American Journal of Pathology|November 12, 2021
Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian HamstersKathleen R Mulka, Sarah E Beck, Clarisse V Solis, et al.
Science (New York, N.Y.)|September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science (New York, N.Y.)|January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionsTimothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Plos Pathogens|August 30, 2024
Step-wise evolution of azole resistance through copy number variation followed by KSR1 loss of heterozygosity in Candida albicansPétra Vande Zande, Cécile Gautier, Nora Kawar, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A genome-scale screen identifies sulfated glycosaminoglycans as pivotal in epithelial cell damage by <i>Candida albicans</i>Jianfeng Lin, Jian Miao, Katherine G Schaefer, et al.
Nature Microbiology|September 16, 2024
Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysinJianfeng Lin, Jian Miao, Katherine G Schaefer, et al.
Molecular Imaging and Biology|August 23, 2021
<sup>124</sup>I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 InfectionCamilo A Ruiz-Bedoya, Filipa Mota, Alvaro A Ordonez, et al.
Plos Pathogens|October 23, 2015
The Fungal Exopolysaccharide Galactosaminogalactan Mediates Virulence by Enhancing Resistance to Neutrophil Extracellular TrapsMark J Lee, Hong Liu, Bridget M Barker, et al.
The American Journal of Pathology|November 12, 2021
Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian HamstersKathleen R Mulka, Sarah E Beck, Clarisse V Solis, et al.
Science (New York, N.Y.)|September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science (New York, N.Y.)|January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionsTimothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Pageof 10